Aemetis (AMTX) Stock Rating Upgraded by Zacks Investment Research  Paula Ricardo | Aug 17th, 2018
Aemetis (NASDAQ:AMTX) was upgraded by Zacks Investment Research from a "hold" rating to a "buy" rating in a research note issued to investors on Wednesday. The firm currently has a $1.50 target price on the specialty chemicals company's stock. Zacks Investment Research 's target price suggests a potential upside of 25.00% from the stock's current price.
According to Zacks, "Aemetis, Inc. is an advanced fuels and renewable chemicals company. It produces renewable chemicals and fuels using patented microbes and processes. Aemetis owns and operates an ethanol animal feed plant in California to produce D5 Advanced Biofuels using the sorghum/biogas/CHP pathway. The Company also built, owns, and operates a renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis, Inc. is headquartered in Cupertino, California. " Get Aemetis alerts:
Separately, B. Riley set a $2.00 price objective on Aemetis and gave the company a "hold" rating in a report on Monday.
Shares of AMTX stock opened at $1.20 on Wednesday. The company has a debt-to-equity ratio of -1.53, a current ratio of 0.27 and a quick ratio of 0.11. Aemetis has a fifty-two week low of $0.45 and a fifty-two week high of $3.12.
Aemetis (NASDAQ:AMTX) last announced its quarterly earnings data on Thursday, August 9th. The specialty chemicals company reported ($0.27) earnings per share for the quarter, beating analysts' consensus estimates of ($0.34) by $0.07. equities research analysts predict that Aemetis will post -1.61 earnings per share for the current year.
About Aemetis
Aemetis, Inc operates as a renewable fuels and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced bio refineries.
Get a free copy of the Zacks research report on Aemetis (AMTX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter . Ã‚